This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (90)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Results of a Long-Term Prospective Study

Ernest L. Mazzaferri, MD; James C. Reynolds, MD; Lt Col Robert L. Young, MC; Lt Col Charles N. Thomas, MC; Alfred F. Parisi, MD

Arch Intern Med. 1976;136(1):50-56.

Abstract
It has been suggested that propranolol hydrochloride alone is effective in the treatment of thyrotoxicosis. To test this hypothesis, eight mildly thyrotoxic individuals were prospectively studied for an average of eight months, during which propranolol alone was administered and thyroid function tests, cardiac systolic time intervals, and body densities were sequentially measured. Two patients became euthyroid. The others had adequate but incomplete symptomatic control. Weight loss was not corrected, but no changes in lean body mass were induced. The augmented myocardial contractility of thyrotoxicosis, as determined by systolic time intervals, improved but failed to return completely to normal. Thus, systolic time intervals are a practical means of following the peripheral response to chronic beta-adrenergic blockade in thyrotoxic patients. However, these observations do not support the use of propranolol alone as the first choice of therapy for thyrotoxicosis.

(Arch Intern Med 136:50-56, 1976)

Author Affiliations
USAF; USAF

From the Division of Endocrinology and Metabolism, Ohio State University Hospitals, Columbus (Drs. Mazzaferri and Reynolds); the divisions of endocrinology and metabolism (Dr. Young) and cardiology (Dr. Thomas), Wilford Hall USAF Medical Center, San Antonio, Texas; and the Division of Cardiology, Baltimore Veterans Administration Hospital, Baltimore (Dr. Parisi).

Footnotes
Received for publication Jan 7, 1975; accepted March 26.

Reprint requests to Room N-1111 University Hospital, 410 W Tenth Ave, Columbus, OH 43210 (Dr. Mazzaferri).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Common Factor for Cardiac or Respiratory Failure in SIDS
Jones
CLIN PEDIATR 1995;34:172-172.
 

The Effect of Diltiazem, a Calcium Channel--Blocking Drug, on Cardiac Rate and Rhythm in Hyperthyroid Patients
Roti et al.
Arch Intern Med 1988;148:1919-1921.
ABSTRACT  

Symptom Rating Scale for Assessing Hyperthyroidism
Klein et al.
Arch Intern Med 1988;148:387-390.
ABSTRACT  

Complications of Propranolol Use in Neonatal Thyrotoxicosis
NEWMAN et al.
Arch Pediatr Adolesc Med 1980;134:707-708.
ABSTRACT  

Cardiac Systolic Time Intervals in Thyroid Disorders
Mazzaferri and Lewis
Arch Intern Med 1978;138:1470-1471.
ABSTRACT  

Effects of Guanadrel on Patients With Thyrotoxicosis
Rubenfeld et al.
Arch Intern Med 1978;138:1106-1108.
ABSTRACT  

Propranolol as Treatment for Thyrotoxicosis
Biran
Arch Intern Med 1976;136:1197-1198.
ABSTRACT